Expression of EphB4 in head and neck squamous cell carcinoma - PubMed (original) (raw)
. 2003 Nov;82(11):866, 869-70, 887.
Affiliations
- PMID: 14661437
Expression of EphB4 in head and neck squamous cell carcinoma
Uttam K Sinha et al. Ear Nose Throat J. 2003 Nov.
Abstract
EphB4 is a receptor tyrosine kinase that is expressed on epithelial cells during fetal life. It is also expressed on some venous endothelial cells. We conducted a study of six men with primary squamous cell carcinoma of the head and neck (HNSCC) that had metastasized to the cervical lymph nodes. Our goal was to determine if EphB4 is aberrantly expressed in cases of HNSCC and to determine if there is a qualitative difference between the expression of EphB4 on primary and metastatic tumors and its expression on normal mucosa adjacent to primary tumors. From each patient, we obtained specimens of the primary tumor, the nodal metastasis, and the adjacent normal mucosa, and we performed immunocytochemistry on each. We observed EphB4 expression in all primary and metastatic tumors and no expression in the normal tissue. In each of the six patients, expression was greater in the metastatic tumor than in the primary tumor. We conclude that EphB4 is a novel target in the treatment of HNSCC.
Similar articles
- The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS. Sinha UK, et al. Arch Otolaryngol Head Neck Surg. 2006 Oct;132(10):1053-9. doi: 10.1001/archotol.132.10.1053. Arch Otolaryngol Head Neck Surg. 2006. PMID: 17043250 - Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA. Sniezek JC, et al. Laryngoscope. 2004 Dec;114(12):2063-72. doi: 10.1097/01.mlg.0000149437.35855.4b. Laryngoscope. 2004. PMID: 15564824 - The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R. Yavrouian EJ, et al. Arch Otolaryngol Head Neck Surg. 2008 Sep;134(9):985-91. doi: 10.1001/archotol.134.9.985. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18794445 - Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck.
Wang J, Xi L, Gooding W, Godfrey TE, Ferris RL. Wang J, et al. Adv Otorhinolaryngol. 2005;62:121-33. doi: 10.1159/000082501. Adv Otorhinolaryngol. 2005. PMID: 15608423 Review. - EphB4: A promising target for upper aerodigestive malignancies.
Salgia R, Kulkarni P, Gill PS. Salgia R, et al. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. Epub 2018 Jan 31. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29369779 Free PMC article. Review.
Cited by
- Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IRA Signal in Malignant Mesothelioma.
Scalia P, Merali C, Barrero C, Suma A, Carnevale V, Merali S, Williams SJ. Scalia P, et al. Int J Mol Sci. 2023 Apr 17;24(8):7380. doi: 10.3390/ijms24087380. Int J Mol Sci. 2023. PMID: 37108544 Free PMC article. - Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.
Kubo H, Yagyu S, Nakamura K, Yamashima K, Tomida A, Kikuchi K, Iehara T, Nakazawa Y, Hosoi H. Kubo H, et al. Mol Ther Oncolytics. 2021 Mar 5;20:646-658. doi: 10.1016/j.omto.2021.03.001. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33816783 Free PMC article. - Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling.
Tang Y, Lei Y, Huang S, Li Z, Chen X, Luo H, Cheng C, Chen J, Zou X, Chen X. Tang Y, et al. Oxid Med Cell Longev. 2020 Jul 10;2020:7409853. doi: 10.1155/2020/7409853. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32733636 Free PMC article. - The IGF-II-Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives.
Scalia P, Giordano A, Williams SJ. Scalia P, et al. Cancers (Basel). 2020 Feb 5;12(2):366. doi: 10.3390/cancers12020366. Cancers (Basel). 2020. PMID: 32033443 Free PMC article. Review. - Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma.
Scalia P, Pandini G, Carnevale V, Giordano A, Williams SJ. Scalia P, et al. Oncogene. 2019 Aug;38(31):5987-6001. doi: 10.1038/s41388-019-0854-y. Epub 2019 Jul 3. Oncogene. 2019. PMID: 31270394 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous